89Zr-Bevacizumab PET in paediatric HGG & DIPG

• Research type

  Research Study

• Full title

  Exploration of VEGF-expression and 89Zirconium-bevacizumab uptake in paediatric high grade glioma and diffuse intrinsic pontine glioma imaged by PET

• IRAS ID

  110530

• Contact name

  Jamshed Bomanji

• Contact email

  jamshed.bomanji@uclh.nhs.uk

• Sponsor organisation

  VU University Medical Center

• REC name

  London - Camden & Kings Cross Research Ethics Committee

• REC reference

  14/LO/0396

• Date of REC Opinion

  7 Aug 2015

• REC opinion

  Further Information Favourable Opinion